Standard Life Aberdeen »

iShares NASDAQ Biotechnology Index shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.9M 44k 135.85

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)

View all positions for Standard Life Aberdeen

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Elliott Investment Management
Goldman Sachs Group
Citigroup
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co
UBS Group
Citadel Advisors
Royal Bank of Canada
Susquehanna International
Barclays
Commerce Bank N A
Wells Fargo & Company
Main Management ETF Advisors
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding iShares NASDAQ Biotechnology Index